Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Hodgkin Disease 24Lymphoma 21Testicular Neoplasms 6Teratoma 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Non-Hodgkin 5Endodermal Sinus Tumor 5Testicular Germ Cell Tumor 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Follicular 4HIV Infections 4Carcinoma, Embryonal 4Acquired Immunodeficiency Syndrome 4Sarcoma, Kaposi 3Ovarian Neoplasms 3Ovarian Germ Cell Cancer 3Head and Neck Neoplasms 3Teratoma, Testicular 2Seminoma 2Neoplasms, Germ Cell and Embryonal 2Neoplasms 2Neoplasm Metastasis 2Cardiotoxicity 2Carcinoma, Squamous Cell 2Carcinoma 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pleural Effusion, Malignant 1Mediastinal Neoplasms 1

Interventions

Talc 5Cisplatin 2viscum album peptide 1Thoracoscopy 1Povidone-Iodine 1Doxycycline 1Darbepoetin alfa 1Bleomycin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Pleural Effusion, Malignant × Bleomycin × Clear all
NCT00002872 2023-06-22

Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions

Eastern Cooperative Oncology Group

Phase 3 Completed
480 enrolled
Thoracic

Neoplasm Metastasis, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡